Quick Downsides: Prana Biotechnology (PRAN), SUPERVALU (SVU), SolarCity ...

19-11-2013 Markets EmergingComments (0)

BiotechnologyPrana Biotechnology

Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) plunged 8.87% yesterday to end Monday at $4.93 after issuing an update on the IMAGINE Phase 2 trial for Alzheimer's Disease. The company disclosed that 29 patients of the 42 patients originally ...

Read more on Markets Emerging

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top